A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2006
11/16/2006	CA2607333A1 Preparation of therapeutic foam
11/16/2006	CA2607272A1 Formulations of mast cell stabilizing agents for delivery to the colon
11/16/2006	CA2607228A1 Compositions and methods using microspheres and non-ionic contrast agents
11/16/2006	CA2607181A1 A non-surgical method for preventing or reducing the rate of the progression of non-proliferative diabetic retinopathy and the treatment of other ocular conditions
11/16/2006	CA2607014A1 Suspension formulations of nepafenac and other ophthalmic drugs for topical treatment of ophthalmic disorders
11/16/2006	CA2606997A1 Stabilizer molecule-depleted albumin solution
11/16/2006	CA2606390A1 Stable lyophilized anthracycline glycosides
11/16/2006	CA2605341A1 Modified-release pharmaceutical compositions
11/16/2006	CA2604052A1 Methods and compositions for the treatment of cns-related conditions
11/16/2006	CA2603069A1 Ocular therapy using alpha-2 adrenergic receptor agonists having enhanced anterior clearance rates
11/15/2006	EP1722227A2 Epitopes formed by non-covalent association of conjugates
11/15/2006	EP1721620A1 Directly-compressible xylitol powder
11/15/2006	EP1721619A1 Soft capsule preparation
11/15/2006	EP1721618A2 Proteosome influenza vaccine composition
11/15/2006	EP1721606A2 Buffered compositions for dialysis
11/15/2006	EP1721605A1 Methods of treating capsules and dry, powdered pharmaceutical formulations
11/15/2006	EP1721604A1 Stable capsule preparation
11/15/2006	EP1721603A1 Nanoparticles for bioconjugation
11/15/2006	EP1721602A1 Controlled release oral drug delivery system
11/15/2006	EP1720577A2 Ciclesonide and glycopyrronium combination
11/15/2006	EP1720565A1 Co-encapsulated wt1 polypeptide and immunostimulant microsphere formulations and methods thereof
11/15/2006	EP1720557A2 Rapidly disintegrating taste-masked tablet
11/15/2006	EP1720551A1 Alkaloid formulations
11/15/2006	EP1720534A1 Method and composition for burned skin
11/15/2006	EP1720533A2 Amoxicillin instant granulate
11/15/2006	EP1720532A1 Controlled release formulations
11/15/2006	EP1720531A2 New compositions containing quinoline compounds
11/15/2006	EP1720529A2 Kit comprising a plaster that optionally contains an active ingredient and an agent that prevents skin irritation
11/15/2006	EP1720528A2 Layered silicate nanoparticle-polymer composite medical articles
11/15/2006	EP1720527A2 A stable pharmaceutical composition comprising an acid labile drug
11/15/2006	EP1720526A1 Coated conditioners for use in foods and pharmaceuticals
11/15/2006	EP1720525A1 Powdered compositions of sensitive active materials in an at least partially amorphous state
11/15/2006	EP1720524A2 Extended release tablets of clarithromycin
11/15/2006	EP1720523A2 Cyclosporin formulations
11/15/2006	EP1720522A1 Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, dna vaccination and administration of gene based drugs
11/15/2006	EP1720521A2 Improved efficacy and safety of targeted particulate agents with decoy systems
11/15/2006	EP1720520A2 Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
11/15/2006	EP1720519A1 Lyophilization method to improve excipient crystallization
11/15/2006	EP1720518A1 Alginate viscoelastic composition, method of use and package
11/15/2006	EP1720517A1 Phase transformation in molecular solids
11/15/2006	EP1720516A2 Expandable gastric retention device
11/15/2006	EP1720498A2 Abuse potential reduction in abusable substance dosage form
11/15/2006	EP1633334B1 Topical administration of vasoactive vitamin b3 compounds for promoting sleep
11/15/2006	EP1492417B1 Encapsulated agglomeration of microcapsules and method for the preparation thereof
11/15/2006	EP1389092B1 Abuse-resistant opioid dosage form
11/15/2006	EP1353968B1 Linear block copolymer
11/15/2006	EP1315479B1 Pectin film compositions
11/15/2006	EP1272197B1 Combination of lecithin with ascorbic acid
11/15/2006	EP1254659B1 Stable emulsion compositions
11/15/2006	EP1152731B1 A skin care composition that mediates cell to cell communication
11/15/2006	EP1105107B1 Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
11/15/2006	EP1093363B1 Compositions for treatment of disorders associated with chlamydia
11/15/2006	EP1042388B1 Polyhydroxyalkanoate compositions having controlled degradation rates
11/15/2006	EP1009430B1 Oil in water emulsion vaccines against Hepatitis B
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0873127B1 Anthelmintic macrocyclic lactone compositions
11/15/2006	EP0799032B1 Pharmacologic management of snoring
11/15/2006	EP0781123B1 Preparation of multivesicular liposomes for controlled release of active agents
11/15/2006	CN2836803Y Car sickness therapeutic plaster
11/15/2006	CN1863866A Finely particulate composite containing carbon compound encapsulated therein
11/15/2006	CN1863734A Highly oil absorbing amorphous silica particles
11/15/2006	CN1863588A Device and method for making particles
11/15/2006	CN1863562A Pressure-sensitive adhesive sheet for application to skin
11/15/2006	CN1863559A 化合物 Compound
11/15/2006	CN1863558A Polyarginine-modified liposome capable of transferring into nucleus
11/15/2006	CN1863557A In-situ gelling drug delivery system
11/15/2006	CN1863535A Noncrystalline antibacterial composition containing cefditoren pivoxil
11/15/2006	CN1863522A Ophthalmic composition for treating lacrimal disorders
11/15/2006	CN1863519A Hydrogel compositions with an erodible backing member
11/15/2006	CN1863518A Pharmaceutical composition containing fenofibrate and method for the preparation thereof
11/15/2006	CN1863517A Rapidly disintegrating formulation
11/15/2006	CN1863516A Multilayer dosage form comprising a matrix that influences release of a modulatory substance
11/15/2006	CN1863515A Multilayer pharmaceutical dosage form containing a substance that acts in a modulatory manner with regard to the release of active substances
11/15/2006	CN1863514A Abuse-proffed dosage form
11/15/2006	CN1863513A Abuse-proffed dosage form
11/15/2006	CN1863512A A controlled release pharmaceutical composition and a process for preparing the same
11/15/2006	CN1863511A Dosage forms of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors
11/15/2006	CN1863510A Micro-particle fatty acid salt solid dosage formulations for therapeutic agents
11/15/2006	CN1863509A Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination with rapamycin
11/15/2006	CN1863508A Target-directed and enteric absorption-controlled liposome having sugar chain and cancer remedy and diagnostic containing the same
11/15/2006	CN1863507A Remedy or diagnostic for inflammatory disease containing target-directing liposome
11/15/2006	CN1863506A Methods for preparing oil bodies comprising active ingredients
11/15/2006	CN1863505A Novel liquid preparation composition
11/15/2006	CN1863504A Long term drug delivery devices with polyurethane based polymers and their manufacture
11/15/2006	CN1861634A Dog interferon alpha, preparation process and use thereof
11/15/2006	CN1861626A Metallic salt kind medicine containing glycyrrhizic hypoglycyrrhizic or its derivant and preparation process thereof
11/15/2006	CN1861623A Asparagic acid azithromycin and preparation thereof
11/15/2006	CN1861608A Crystalline solvate of cefuroxime acid
11/15/2006	CN1861193A Kidney target precursor medicine, said prepn., its preparing method and application
11/15/2006	CN1861192A Camptothecin type medicine loaded on high molecular nano-microsphere, and its prepn. method
11/15/2006	CN1861189A Medicinal composition for eliminating infection and reduplication of influenza-virus
11/15/2006	CN1861188A Aerosol contg. met-enkephalin
11/15/2006	CN1861186A Medicinal composition for treating chronic pelvic inflammatory disease, prepn. method and quality control method therefor
11/15/2006	CN1861185A Method for preparing coated tablets for treating cholecystitis
11/15/2006	CN1861183A Traditional Chinese medicine capsule for treating mammary gland diseases
11/15/2006	CN1861182A Honey prepd. Chunsha Yangwei syrup for treating stomach trouble
11/15/2006	CN1861181A Medicine for treating epilepsy and its prepn. method
11/15/2006	CN1861179A Pure traditional Chinese medicine composition and its prepn. method
11/15/2006	CN1861177A Medicinal composition for treating children cold and its prepn. process
11/15/2006	CN1861176A Medicinal composition for treating diabets, and its prepn. method

1 ... 1534 1535 1536 1537 1538 1539 1540 1541 1542 1543 1544 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 ... 2991